Published in Infect Immun on February 01, 1979
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol (1988) 3.84
Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun (1982) 3.02
Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun (1981) 2.49
Protective immunization of mice with specific HSV-1 glycoproteins. Immunology (1983) 1.77
Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J Virol (1986) 1.43
Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes. Infect Immun (1983) 1.43
Role of antibody in primary and recurrent herpes simplex virus infection. J Virol (1985) 1.41
Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice. Infect Immun (1980) 1.32
Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells. J Virol (2001) 1.21
Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections. Infect Immun (1981) 1.21
Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1. Infect Immun (1981) 1.01
Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia. J Virol (1984) 0.95
Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts. J Virol (2000) 0.92
Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice. J Virol (2000) 0.92
Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus. J Virol (2010) 0.91
Antibody responses in humans to individual proteins of herpes simplex viruses. Infect Immun (1981) 0.91
Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization. Acta Neuropathol (1987) 0.91
Induction of 2',5'-oligoadenylate synthetase and interferon in mouse trigeminal ganglia infected with herpes simplex virus. Infect Immun (1980) 0.89
Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cells. Virology (2008) 0.88
Localization of a passively transferred human recombinant monoclonal antibody to herpes simplex virus glycoprotein D to infected nerve fibers and sensory neurons in vivo. J Virol (1999) 0.88
Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine. J Virol (1985) 0.83
Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice. Antimicrob Agents Chemother (2000) 0.82
Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine. J Virol (1992) 0.80
Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs. PLoS One (2014) 0.79
Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin. Antimicrob Agents Chemother (1987) 0.77
Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1. Antimicrob Agents Chemother (2001) 0.76
Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect Immun (1973) 5.29
THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING. J Exp Med (1964) 4.39
A serologic study of herpesvirus hominis strains by microneutralization tests. J Immunol (1967) 4.39
A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol (1970) 4.12
The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med (1977) 3.61
Minicultures of mammalian cells in a new plastic plate. Appl Microbiol (1969) 2.45
Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection. Infect Immun (1975) 2.44
Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol (1976) 2.34
Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization. Science (1975) 1.95
Spread of herpes simplex virus in peripheral nerves. Acta Neuropathol (1971) 1.87
Morphological studies of the neural spread of herpes simplex virus to the central nervous system. Acta Neuropathol (1970) 1.32
Passive immunization in experimental Herpesvirus hominis infection of newborn mice. Infect Immun (1975) 1.31
Production of interferon by immune lymphocytes exposed to herpes simplex virus-antibody complexes. J Immunol (1975) 1.18
Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection. Infect Immun (1976) 1.15
Pathogenesis of herpes simplex virus types 1 and 2 in mice after various routes of inoculation. Infect Immun (1976) 1.02
Herpes virus latency in spinal ganglia of mice without illness. Proc Soc Exp Biol Med (1974) 1.00
Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med (1973) 5.66
Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immun (1980) 5.03
Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med (1974) 4.49
Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet (2001) 4.31
Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet (1996) 3.17
Tissue adhesives for traumatic lacerations in children and adults. Cochrane Database Syst Rev (2002) 3.08
Theiler's virus persists in glial cells during demyelinating disease. Cell (1981) 2.67
Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun (1981) 2.49
Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect Immun (1983) 2.21
Giant axonal neuropathy--a unique case with segmental neurofilamentous masses. Acta Neuropathol (1972) 1.91
The structural polypeptides of RNA slow viruses. Virology (1974) 1.81
Experimental herpes simplex encephalitis: early neuropathologic changes. J Neuropathol Exp Neurol (1970) 1.65
Herpes simplex virus infection of nervous tissue in animals and man. Prog Med Virol (1975) 1.52
Sensory perineuritis. Arch Neurol (1972) 1.51
Acquired toxoplasmosis. A neglected cause of treatable nervous system disease. Arch Neurol (1975) 1.44
Detection of Theiler's virus RNA in mouse central nervous system by in situ hybridization. Lab Invest (1981) 1.43
Partial purification and evidence for multiple molecular forms of the scrapie agent. Biochemistry (1978) 1.42
An acute syndrome of ocular oscillations and truncal myoclonus. Brain (1968) 1.31
Tubular aggregates in endoplasmic reticulum in herpes-simplex encephalitis. N Engl J Med (1971) 1.29
Progressive rubella panencephalitis. Late onset after congenital rubella. N Engl J Med (1975) 1.28
Chronic hypoventilation of central origin. A case with encephalitis lethargica and Parkinson's syndrome. Am Rev Respir Dis (1967) 1.28
Tubular aggregates in endoplasmic reticulum: evidence against their viral nature. J Ultrastruct Res (1972) 1.23
Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. Am J Physiol Cell Physiol (2000) 1.21
Virus-like particles and nucleoprotein-type filaments in brain tissue from two patients with Creutzfeldt-Jakob disease. Lancet (1970) 1.21
Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice. Infect Immun (1977) 1.21
The numb chin in metastatic cancer. West J Med (1991) 1.16
IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: role for neutralization and Fc-dependent functions but not C' cytolysis and C5 chemotaxis. J Infect Dis (1985) 1.14
Recurrent herpes simplex encephalitis: recovery of virus after Ara-A treatment. Ann Neurol (1983) 1.08
Radioimmunoassay of herpes simplex virus antibody: correlation with ganglionic infection. J Gen Virol (1977) 1.07
Persistent herpes simplex virus infection in rabbit trigeminal ganglia. Lab Invest (1974) 1.05
The significance of giant vacuolation of endoneurial fibroblasts. Acta Neuropathol (1971) 1.05
Ultrastructure of mumps virus replication in newborn hamster central nervous system. Lab Invest (1974) 1.04
The neuropathology of progressive rubella panencephalitis of late onset. Brain (1976) 1.04
Experimental scrapie in mice: ultrastructural observations. Ann Neurol (1978) 1.02
Cardiac resynchronization therapy for congestive heart failure. Evid Rep Technol Assess (Summ) (2004) 1.01
Herpes virus latency in spinal ganglia of mice without illness. Proc Soc Exp Biol Med (1974) 1.00
Herpetic proctitis and meningitis: recovery of two strains of herpes simplex virus type 1 from cerebrospinal fluid. J Infect Dis (1982) 0.99
Persistent, slow and latent viral infections. Prog Med Virol (1982) 0.96
Comparative neurovirulence and latency of HSV1 and HSV2 following footpad inoculation in mice. J Med Virol (1980) 0.96
Morphology of central nervous system disease in immunosuppressed mice after peripheral herpes simplex virus inoculation. Trigeminal root entry zone. Lab Invest (1979) 0.95
Detection of tissue culture-adapted Theiler's virus RNA in spinal cord white matter cells throughout infection. Infect Immun (1982) 0.95
Delayed stroke following carotid occlusion. Neurology (1980) 0.94
Central nervous system susceptibility to herpes simplex infection. J Neuropathol Exp Neurol (1978) 0.94
Experimental herpes simplex encephalitis. Treatment with pyrimidine nucleosides. Arch Neurol (1973) 0.93
Scrapie-associated particles in postsynaptic processes. Further ultrastructural studies. J Neuropathol Exp Neurol (1981) 0.93
Cortical MRI findings associated with rapid correction of hyponatremia. Neurology (2000) 0.92
Experimental measles virus encephalitis. A light, phase, fluorescence, and electron microscopic study. Lab Invest (1970) 0.91
Biochemistry of Theiler's murine encephalomyelitis virus isolated from acutely infected mouse brain: identification of a previously unreported polypeptide. Infect Immun (1981) 0.91
Progressive myelopathy due to extramedullary hematopoiesis: case report and review of the literature. Ann Neurol (1979) 0.90
Scrapie infection diminishes spines and increases varicosities of dendrites in hamsters: a quantitative Golgi analysis. J Neuropathol Exp Neurol (1987) 0.90
Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol (1989) 0.90
Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J Infect Dis (1976) 0.89
Progressive retinal degeneration in scrapie-infected hamsters: a light and electron microscopic analysis. Lab Invest (1981) 0.89
Melatonin for treatment of sleep disorders. Evid Rep Technol Assess (Summ) (2004) 0.89
Nocardial cerebral abscess in the acquired immunodeficiency syndrome. Arch Neurol (1987) 0.89
Neuropathology of progressive rubella panencephalitis after childhood rubella. Neurology (1982) 0.89
A simplified procedure for spinal fluid cytology. Arch Neurol (1970) 0.88
Replication of the scrapie agent in hamster brain precedes neuronal vacuolation. J Neuropathol Exp Neurol (1983) 0.88
Delayed IgG-mediated clearance of herpes simplex virus type 1 from the CNS but not footpad during the early stages of infection: possible result of relative integrity of the blood-brain barrier. J Gen Virol (1983) 0.88
Experimental herpes simplex virus encephalitis. Effect of corticosteroids and pyrimidine nucleoside. Arch Neurol (1976) 0.87
Reovirus-induced aqueductal stenosis in hamsters. Phase contrast and electron microscopic studies. Lab Invest (1972) 0.87
Immunochemical features of a case of progressive rubella panencephalitis. Clin Exp Immunol (1982) 0.87
Herpes simplex virus and Bell palsy. Ann Intern Med (1996) 0.86
A new look at mumps encephalitis: inclusion bodies and cytopathic effects. J Neuropathol Exp Neurol (1974) 0.86
Correlation between detection of herpes simplex virus in oral secretions by PCR and susceptibility to experimental UV radiation-induced herpes labialis. J Clin Microbiol (1994) 0.86
Intravascular lymphomatosis: contribution of cerebral MRI findings to diagnosis. J Neuroimaging (2000) 0.84
Calciphylaxis mimicking dermatomyositis: ischemic myopathy complicating renal failure. Neurology (1998) 0.84
Impaired migratory and chemotactic activity of neutrophils during murine cytomegalovirus infection. J Infect Dis (1983) 0.84
Symptomatic hyponatraemia: can myelinolysis be prevented by treatment? J Neurol Neurosurg Psychiatry (1993) 0.83
Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia. J Neurol Sci (1971) 0.83
Cerebrovascular syndromes following cardiac transplantation. Neurology (1992) 0.82
Isolation of herpes simplex virus type I in recurrent (Mollaret) meningitis. Ann Neurol (1982) 0.82
Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis. Arch Neurol (1989) 0.82
MRI abnormalities in chronic active varicella zoster infection. Neurology (2004) 0.81
Ultrastructure of mumps virus replication in organotypic cultures of hamster choroid plexus. J Gen Virol (1976) 0.81
Drs harris and baringer respond. West J Med (1992) 0.81
Replication of scrapie prions in hamster eyes precedes retinal degeneration. Ophthalmic Res (1986) 0.81
Retinal degeneration in experimental Creutzfeldt-Jakob disease. Lab Invest (1983) 0.81
A case of Marchiafavabignami disease with clinical recovery. Trans Am Neurol Assoc (1965) 0.81
Subacute measles encephalitis complicating Hodgkin's disease in an adult. Ann Neurol (1977) 0.81
Parvovirus hemorrhagic encephalopathy of rats. Electron microscopic observations of the vascular lesions. Lab Invest (1972) 0.80
Use of aggregating brain cultures to study the replication of herpes simplex virus types 1 and 2 in central nervous system tissue. J Virol Methods (1984) 0.80
Latent herpes simplex virus infection in human trigeminal ganglia. Trans Am Neurol Assoc (1973) 0.80
Spread of herpes simplex virus type 1 in the central nervous system during experimentally reactivated encephalitis. Microb Pathog (1990) 0.80
Diagnosis and management of work-related asthma. Evid Rep Technol Assess (Summ) (2005) 0.80
Lymphoid cell infection by measles virus in newborn hamsters. Role for monocytes in virus spread to distant sites. J Neuroimmunol (1981) 0.80
Herpes-simplex antigen in rabbit cerebrospinal fluid. Lancet (1977) 0.80
Plasma exchange: a treatment for neuropathy associated with IgG-kappa gammopathy. J Neurol (1990) 0.79
Evidence for hydrophobic domains on the surface of the scrapie agent. Trans Am Neurol Assoc (1978) 0.78
CNS disease following dissemination of SSPE measles virus from intraperitoneal inoculation of suckling hamsters. J Med Virol (1978) 0.78
Experimental herpes encephalitis: crystalline arrays in endoplasmic reticulum. Science (1969) 0.78
Identity of cowdry type B inclusions and nuclear bodies: observations in reovirus encephalitis. Exp Mol Pathol (1975) 0.78
Cytomegalovirus meningoencephalitis in a homosexual man with Kaposi's sarcoma: isolation of CMV from CSF cells. Neurology (1985) 0.77
HTLV-I-associated myelopathy/tropical spastic paraparesis in the United States. Neurology (1991) 0.77